Recommended Potency of Steroid Cream for Various Skin Conditions

General Principles of Topical Steroid Selection

The American Academy of Dermatology recommends selecting the appropriate potency of topical corticosteroids based on the specific skin condition, location, severity, and patient characteristics, with moderate to high potency generally recommended as initial therapy for most adult plaque psoriasis 1
The American Academy of Dermatology suggests that topical corticosteroids are classified into 7 categories based on their vasoconstrictive activity, ranging from ultra-high potency to low potency 1
The selection of topical corticosteroids should consider disease severity, location, patient preference, and patient age, according to the American Academy of Dermatology 1
Lower potency corticosteroids should be used on the face, intertriginous areas, and areas susceptible to steroid atrophy, as recommended by the American Academy of Dermatology 1

For plaque psoriasis not involving intertriginous areas, the American Academy of Dermatology recommends classes 2-5 (high to moderate potency) as initial therapy for most adult cases, with a treatment duration of up to 4 weeks 1, 2
For scalp psoriasis, the American Academy of Dermatology recommends classes 1-7 (any potency) for a minimum of up to 4 weeks for initial and maintenance treatment 1

For mild disease, low to moderate potency steroids are appropriate, and very potent topical steroids should be avoided, according to the British Medical Journal 3, 4
For moderate to severe disease, medium potency steroids can be utilized for longer courses, and high potency steroids are useful for treating severe disease and flares, as recommended by the American Academy of Dermatology 5

For localized or mild disease, very potent topical steroids alone applied to lesional skin are recommended, with a strength of recommendation A, by the British Journal of Dermatology 6
For moderate-to-severe disease, very potent topical steroids 5-15g twice daily to whole skin surface are recommended, with a strength of recommendation A, by the British Journal of Dermatology 6

For recent onset, potent or very potent topical steroid for a trial period of no more than 2 months is recommended, and topical pimecrolimus or tacrolimus should be considered as alternatives, according to the British Journal of Dermatology 7

For grade 1-2 reactions, high-potency topical steroids twice daily are recommended, by the Annals of Oncology 8, 9
For grade ≥3 or intolerable grade 2, high-potency topical steroids twice daily, with treatment interruption until severity decreases, are recommended, by the Annals of Oncology 8, 9

Longer-term use of topical corticosteroids (>12 weeks) can be considered under careful physician supervision, according to the American Academy of Dermatology 1

Avoid using high potency steroids on the face, intertriginous areas, and areas susceptible to steroid atrophy, as recommended by the American Academy of Dermatology 1
Undertreatment due to steroid phobia is common; proper education about benefits and risks is important, according to the British Medical Journal 3, 4

Topical corticosteroids used together with soap substitutes and emollients constitute the accepted standard therapy for established contact dermatitis. 10

If a patient shows no clinical improvement after 2 weeks of twice‑daily application of betamethasone valerate 0.1 % (or any potent corticosteroid), the diagnosis should be reassessed and second‑line treatment options considered. 10

For steroid‑resistant hand eczema, recommended second‑line modalities include PUVA phototherapy, oral alitretinoin, and systemic immunosuppressive agents. 11

Mometasone furoate 0.1 % (potent) is supported by Level I evidence for effective long‑term intermittent use in chronic hand eczema. 10